{"entity":{"type":"insider","cik":"0001742084","url":"/insider/0001742084","json_url":"/insider/0001742084.json","name":"O'Neill Gilmore Neil","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":11,"first":"2023-06-07","last":"2026-06-05","span_basis":"filed_date"},"name_variants":[{"name":"O'Neill Gilmore Neil","source":"filing","n_filings":11,"first_seen":"2023-06-07","last_seen":"2026-06-05"}],"transactions":[{"id":5885234,"accession":"0001650664-26-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001650664-26-000056","line_url":"/filing/0001650664-26-000056#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001742084","owner_name":"O'Neill Gilmore Neil","owner_display_name":"O'Neill Gilmore Neil","owner_url":"/insider/0001742084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15380.0,"shares_display":"15,380","price_per_share":2.7011,"price_display":"2.70","price_state":"stated","total_value":41542.918,"total_display":"41,542.92","total_whole":"41,543","shares_owned_after":248313.0,"shares_owned_after_display":"248,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-03","filed_date":"2026-06-05","scope":"insider"},{"id":5848462,"accession":"0001650664-26-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001650664-26-000009","line_url":"/filing/0001650664-26-000009#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001742084","owner_name":"O'Neill Gilmore Neil","owner_display_name":"O'Neill Gilmore Neil","owner_url":"/insider/0001742084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5394.0,"shares_display":"5,394","price_per_share":2.0197,"price_display":"2.02","price_state":"stated","total_value":10894.2618,"total_display":"10,894.26","total_whole":"10,894","shares_owned_after":263693.0,"shares_owned_after_display":"263,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider"},{"id":4811826,"accession":"0001650664-25-000162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001650664-25-000162","line_url":"/filing/0001650664-25-000162#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001742084","owner_name":"O'Neill Gilmore Neil","owner_display_name":"O'Neill Gilmore Neil","owner_url":"/insider/0001742084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5603.0,"shares_display":"5,603","price_per_share":2.1531,"price_display":"2.15","price_state":"stated","total_value":12063.8193,"total_display":"12,063.82","total_whole":"12,064","shares_owned_after":269087.0,"shares_owned_after_display":"269,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-04","scope":"insider"},{"id":4072535,"accession":"0001650664-25-000141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001650664-25-000141","line_url":"/filing/0001650664-25-000141#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001742084","owner_name":"O'Neill Gilmore Neil","owner_display_name":"O'Neill Gilmore Neil","owner_url":"/insider/0001742084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5592.0,"shares_display":"5,592","price_per_share":2.5961,"price_display":"2.60","price_state":"stated","total_value":14517.3912,"total_display":"14,517.39","total_whole":"14,517","shares_owned_after":274690.0,"shares_owned_after_display":"274,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-04","scope":"insider"},{"id":4437380,"accession":"0001650664-25-000089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001650664-25-000089","line_url":"/filing/0001650664-25-000089#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001742084","owner_name":"O'Neill Gilmore Neil","owner_display_name":"O'Neill Gilmore Neil","owner_url":"/insider/0001742084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15192.0,"shares_display":"15,192","price_per_share":1.7243,"price_display":"1.72","price_state":"stated","total_value":26195.5656,"total_display":"26,195.57","total_whole":"26,196","shares_owned_after":280282.0,"shares_owned_after_display":"280,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-04","scope":"insider"},{"id":4811812,"accession":"0001650664-25-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001650664-25-000026","line_url":"/filing/0001650664-25-000026#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001742084","owner_name":"O'Neill Gilmore Neil","owner_display_name":"O'Neill Gilmore Neil","owner_url":"/insider/0001742084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16632.0,"shares_display":"16,632","price_per_share":1.7107,"price_display":"1.71","price_state":"stated","total_value":28452.3624,"total_display":"28,452.36","total_whole":"28,452","shares_owned_after":295474.0,"shares_owned_after_display":"295,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-05","scope":"insider"},{"id":3270116,"accession":"0001650664-24-000126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001650664-24-000126","line_url":"/filing/0001650664-24-000126#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001742084","owner_name":"O'Neill Gilmore Neil","owner_display_name":"O'Neill Gilmore Neil","owner_url":"/insider/0001742084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1618.0,"shares_display":"1,618","price_per_share":2.0774,"price_display":"2.08","price_state":"stated","total_value":3361.2332,"total_display":"3,361.23","total_whole":"3,361","shares_owned_after":312106.0,"shares_owned_after_display":"312,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-03","filed_date":"2024-12-05","scope":"insider"},{"id":2491815,"accession":"0001650664-24-000103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001650664-24-000103","line_url":"/filing/0001650664-24-000103#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001742084","owner_name":"O'Neill Gilmore Neil","owner_display_name":"O'Neill Gilmore Neil","owner_url":"/insider/0001742084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1555.0,"shares_display":"1,555","price_per_share":3.4247,"price_display":"3.42","price_state":"stated","total_value":5325.4085,"total_display":"5,325.41","total_whole":"5,325","shares_owned_after":313724.0,"shares_owned_after_display":"313,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-04","filed_date":"2024-09-06","scope":"insider"},{"id":2705719,"accession":"0001650664-24-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001650664-24-000076","line_url":"/filing/0001650664-24-000076#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001742084","owner_name":"O'Neill Gilmore Neil","owner_display_name":"O'Neill Gilmore Neil","owner_url":"/insider/0001742084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12191.0,"shares_display":"12,191","price_per_share":5.4956,"price_display":"5.50","price_state":"stated","total_value":66996.8596,"total_display":"66,996.86","total_whole":"66,997","shares_owned_after":315279.0,"shares_owned_after_display":"315,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-06","scope":"insider"},{"id":2705715,"accession":"0001650664-24-000015","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001650664-24-000015","line_url":"/filing/0001650664-24-000015#line-4","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001742084","owner_name":"O'Neill Gilmore Neil","owner_display_name":"O'Neill Gilmore Neil","owner_url":"/insider/0001742084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77824.0,"shares_display":"77,824","price_per_share":9.4172,"price_display":"9.42","price_state":"stated","total_value":732884.1728,"total_display":"732,884.17","total_whole":"732,884","shares_owned_after":327470.0,"shares_owned_after_display":"327,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-05","scope":"insider"},{"id":7981068,"accession":"0001415889-23-009369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-009369","line_url":"/filing/0001415889-23-009369#line-1","is_derivative":false,"issuer_cik":"0001650664","issuer_name":"Editas Medicine, Inc.","issuer_ticker":"EDIT","issuer_name_source":null,"issuer_url":"/issuer/0001650664","owner_cik":"0001742084","owner_name":"O'Neill Gilmore Neil","owner_display_name":"O'Neill Gilmore Neil","owner_url":"/insider/0001742084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6486.0,"shares_display":"6,486","price_per_share":9.5032,"price_display":"9.50","price_state":"stated","total_value":61637.7552,"total_display":"61,637.76","total_whole":"61,638","shares_owned_after":130169.0,"shares_owned_after_display":"130,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001650664","name":"Editas Medicine, Inc.","url":"/issuer/0001650664","role":"Director, Officer (CEO)","n_filings":11,"first_seen":"2023-06-07","last_seen":"2026-06-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001742084","retrieved_at":"2026-08-23T01:52:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}